Literature DB >> 16337177

Vaccines against cysticercosis and hydatidosis: foundations in taeniid cestode immunology.

Marshall W Lightowlers1.   

Abstract

Recombinant oncosphere antigens have been used in the development of effective vaccines for the prevention of cysticercosis caused by Taenia ovis, Taenia saginata, Taenia solium and hydatid disease caused by Echinococcus granulosus. These vaccines were developed utilizing information gathered from numerous researchers over some 60 years which had established many of the principals concerning immunity to taeniid cestodes in their intermediate hosts. Australian scientists, or scientists with close Australian connections, made seminal early contributions to the understanding of cestode immunology that provided the foundations for more recent application of recombinant DNA methods and the development of practical vaccines. Here, some particular contributions to the field are highlighted from Drs. Michael Gemmell, Michael Rickard, David Heath and Graham Mitchell together with a précis of the recent progress in vaccine development, particularly for prevention of cysticercosis due to T. solium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337177     DOI: 10.1016/j.parint.2005.11.005

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  13 in total

1.  Efficacy of radical and conservative surgery for hepatic cystic echinococcosis: a meta-analysis.

Authors:  Yi-Biao He; Gang Yao; Tuerhongjiang Tuxun; Lei Bai; Tao Li; Jin-Ming Zhao; Jin-Hui Zhang; Hao Wen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Successful immunization of naturally reared pigs against porcine cysticercosis with a recombinant oncosphere antigen vaccine.

Authors:  César M Jayashi; Craig T Kyngdon; Charles G Gauci; Armando E Gonzalez; Marshall W Lightowlers
Journal:  Vet Parasitol       Date:  2012-04-04       Impact factor: 2.738

3.  Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths.

Authors:  Neal Alexander; Bonnie Cundill; Lorenzo Sabatelli; Jeffrey M Bethony; David Diemert; Peter Hotez; Peter G Smith; Laura C Rodrigues; Simon Brooker
Journal:  Vaccine       Date:  2011-03-22       Impact factor: 3.641

Review 4.  Fact or hypothesis: concomitant immunity in taeniid cestode infections.

Authors:  M W Lightowlers
Journal:  Parasite Immunol       Date:  2010-08       Impact factor: 2.280

5.  Analyses of an expressed sequence tag library from Taenia solium, Cysticerca.

Authors:  Jonas Lundström; Fernando Salazar-Anton; Ellen Sherwood; Björn Andersson; Johan Lindh
Journal:  PLoS Negl Trop Dis       Date:  2010-12-21

Review 6.  Synthesising 30 years of mathematical modelling of Echinococcus transmission.

Authors:  Jo-An M Atkinson; Gail M Williams; Laith Yakob; Archie C A Clements; Tamsin S Barnes; Donald P McManus; Yu Rong Yang; Darren J Gray
Journal:  PLoS Negl Trop Dis       Date:  2013-08-29

7.  Evaluation of Immunogenicity of Novel Isoform of EG95 (EG95-5G1) From Echinococcus granulosus in BALB/C Mice.

Authors:  Majid Pirestani; Abdolhossein Dalimi; Shahabodin Sarvi; Nima Khoramabadi
Journal:  Iran J Parasitol       Date:  2014 Oct-Dec       Impact factor: 1.012

8.  Neurocysticercosis-more than a neglected disease.

Authors:  Theodore E Nash; Siddhartha Mahanty; Hector H Garcia
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

9.  The EG95 antigen of Echinococcus spp. contains positively selected amino acids, which may influence host specificity and vaccine efficacy.

Authors:  Karen Luisa Haag; Bruno Gottstein; Francisco Jose Ayala
Journal:  PLoS One       Date:  2009-04-29       Impact factor: 3.240

10.  Genome-wide analysis of regulatory proteases sequences identified through bioinformatics data mining in Taenia solium.

Authors:  Hong-Bin Yan; Zhong-Zi Lou; Li Li; Paul J Brindley; Yadong Zheng; Xuenong Luo; Junling Hou; Aijiang Guo; Wan-Zhong Jia; Xuepeng Cai
Journal:  BMC Genomics       Date:  2014-06-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.